Evaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations

Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is increasing with introduction of new and combination cancer pharmacotherapies. This study evaluated associations between clinical and self-report measurements and current perception threshold (CPT), a neuroselective measure of sensory nerve...

Full description

Saved in:
Bibliographic Details
Published inSupportive care in cancer Vol. 22; no. 5; pp. 1161 - 1169
Main Authors Griffith, Kathleen A., Couture, Darren J., Zhu, Shijun, Pandya, Naimish, Johantgen, Mary E., Cavaletti, Guido, Davenport, Joan M., Tanguay, Lori J., Choflet, Amanda, Milliron, Todd, Glass, Erica, Gambill, Nancy, Renn, Cynthia L., Dorsey, Susan G.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.05.2014
Springer
Springer Nature B.V
Subjects
Antineoplastic Agents - adverse effects
Antineoplastic Agents - therapeutic use
Cancer
Chemotherapy
Female
Humans
Male
Medicine
Medicine & Public Health
Middle Aged
Neoplasms - drug therapy
Neurological disorders
Neurotoxicity Syndromes - diagnosis
Nursing
Nursing Research
Oncology
Original Article
Pain
Pain Medicine
Peripheral Nervous System Diseases - chemically induced
Peripheral Nervous System Diseases - diagnosis
Prospective Studies
Quality of Life
Rehabilitation Medicine
Self Report
Sensory Thresholds - physiology
Chemotherapy
Pain
CIPN
Chemotherapy-induced peripheral neuropathy
Quality of life
Cancer
Online AccessGet full text
ISSN0941-4355
1433-7339
1433-7339
DOI10.1007/s00520-013-2068-0

Cover

Abstract Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is increasing with introduction of new and combination cancer pharmacotherapies. This study evaluated associations between clinical and self-report measurements and current perception threshold (CPT), a neuroselective measure of sensory nerve function that may detect asymptomatic CIPN damage. Methods Data for this secondary analysis were from a prospective, observational study using CPT to evaluate CIPN. Bivariate mixed models, accounting for the intraclass correlation between repeated patient assessments, were used to assess the relationship between CPT at each frequency (5, 250, and 2,000 Hz) and each subjective measure (Neuropathic Pain Scale, FACT-GOGntx) and objective measurement (quantitative sensory testing, deep tendon reflexes, and grip strength). Results A total of 29 chemotherapy-naïve subjects with various cancer types had a mean age of 56.7 (SD 10.4); nine subjects developed CIPN grade >1 using NCI CTC-AE criteria. Cold detection thresholds were inversely associated with CPT 5 [ b (95 % CI) = −2.5(−4.5, −0.5)] and CPT 2,000 [−7.5(−11.8, −3.3)] frequencies. FACT GOG-ntx quality of life (QoL) scale and neurotoxicity and function subscales were inversely associated with CPT 2,000 [−1.8 (−3.5, −0.05), −2.2 (−4.2, −0.2), and −5.4 (−9.8, −0.9), respectively], indicating worsening QoL, impairment, and function as hypoesthesia increases. Conclusions CPT 2,000 may identify impending worsening of patient-reported outcomes such as QoL.
AbstractList Chemotherapy-induced peripheral neuropathy (CIPN) is increasing with introduction of new and combination cancer pharmacotherapies. This study evaluated associations between clinical and self-report measurements and current perception threshold (CPT), a neuroselective measure of sensory nerve function that may detect asymptomatic CIPN damage.PURPOSEChemotherapy-induced peripheral neuropathy (CIPN) is increasing with introduction of new and combination cancer pharmacotherapies. This study evaluated associations between clinical and self-report measurements and current perception threshold (CPT), a neuroselective measure of sensory nerve function that may detect asymptomatic CIPN damage.Data for this secondary analysis were from a prospective, observational study using CPT to evaluate CIPN. Bivariate mixed models, accounting for the intraclass correlation between repeated patient assessments, were used to assess the relationship between CPT at each frequency (5, 250, and 2,000 Hz) and each subjective measure (Neuropathic Pain Scale, FACT-GOGntx) and objective measurement (quantitative sensory testing, deep tendon reflexes, and grip strength).METHODSData for this secondary analysis were from a prospective, observational study using CPT to evaluate CIPN. Bivariate mixed models, accounting for the intraclass correlation between repeated patient assessments, were used to assess the relationship between CPT at each frequency (5, 250, and 2,000 Hz) and each subjective measure (Neuropathic Pain Scale, FACT-GOGntx) and objective measurement (quantitative sensory testing, deep tendon reflexes, and grip strength).A total of 29 chemotherapy-naïve subjects with various cancer types had a mean age of 56.7 (SD 10.4); nine subjects developed CIPN grade >1 using NCI CTC-AE criteria. Cold detection thresholds were inversely associated with CPT 5 [b(95 % CI) = -2.5(-4.5, -0.5)] and CPT 2,000 [-7.5(-11.8, -3.3)] frequencies. FACT GOG-ntx quality of life (QoL) scale and neurotoxicity and function subscales were inversely associated with CPT 2,000 [-1.8 (-3.5, -0.05), -2.2 (-4.2, -0.2), and -5.4 (-9.8, -0.9), respectively], indicating worsening QoL, impairment, and function as hypoesthesia increases.RESULTSA total of 29 chemotherapy-naïve subjects with various cancer types had a mean age of 56.7 (SD 10.4); nine subjects developed CIPN grade >1 using NCI CTC-AE criteria. Cold detection thresholds were inversely associated with CPT 5 [b(95 % CI) = -2.5(-4.5, -0.5)] and CPT 2,000 [-7.5(-11.8, -3.3)] frequencies. FACT GOG-ntx quality of life (QoL) scale and neurotoxicity and function subscales were inversely associated with CPT 2,000 [-1.8 (-3.5, -0.05), -2.2 (-4.2, -0.2), and -5.4 (-9.8, -0.9), respectively], indicating worsening QoL, impairment, and function as hypoesthesia increases.CPT 2,000 may identify impending worsening of patient-reported outcomes such as QoL.CONCLUSIONSCPT 2,000 may identify impending worsening of patient-reported outcomes such as QoL.
Chemotherapy-induced peripheral neuropathy (CIPN) is increasing with introduction of new and combination cancer pharmacotherapies. This study evaluated associations between clinical and self-report measurements and current perception threshold (CPT), a neuroselective measure of sensory nerve function that may detect asymptomatic CIPN damage. Data for this secondary analysis were from a prospective, observational study using CPT to evaluate CIPN. Bivariate mixed models, accounting for the intraclass correlation between repeated patient assessments, were used to assess the relationship between CPT at each frequency (5, 250, and 2,000 Hz) and each subjective measure (Neuropathic Pain Scale, FACT-GOGntx) and objective measurement (quantitative sensory testing, deep tendon reflexes, and grip strength). A total of 29 chemotherapy-naïve subjects with various cancer types had a mean age of 56.7 (SD 10.4); nine subjects developed CIPN grade >1 using NCI CTC-AE criteria. Cold detection thresholds were inversely associated with CPT 5 [b(95 % CI) = -2.5(-4.5, -0.5)] and CPT 2,000 [-7.5(-11.8, -3.3)] frequencies. FACT GOG-ntx quality of life (QoL) scale and neurotoxicity and function subscales were inversely associated with CPT 2,000 [-1.8 (-3.5, -0.05), -2.2 (-4.2, -0.2), and -5.4 (-9.8, -0.9), respectively], indicating worsening QoL, impairment, and function as hypoesthesia increases. CPT 2,000 may identify impending worsening of patient-reported outcomes such as QoL.
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is increasing with introduction of new and combination cancer pharmacotherapies. This study evaluated associations between clinical and self-report measurements and current perception threshold (CPT), a neuroselective measure of sensory nerve function that may detect asymptomatic CIPN damage. Methods Data for this secondary analysis were from a prospective, observational study using CPT to evaluate CIPN. Bivariate mixed models, accounting for the intraclass correlation between repeated patient assessments, were used to assess the relationship between CPT at each frequency (5, 250, and 2,000 Hz) and each subjective measure (Neuropathic Pain Scale, FACT-GOGntx) and objective measurement (quantitative sensory testing, deep tendon reflexes, and grip strength). Results A total of 29 chemotherapy-naïve subjects with various cancer types had a mean age of 56.7 (SD 10.4); nine subjects developed CIPN grade >1 using NCI CTC-AE criteria. Cold detection thresholds were inversely associated with CPT 5 [ b (95 % CI) = −2.5(−4.5, −0.5)] and CPT 2,000 [−7.5(−11.8, −3.3)] frequencies. FACT GOG-ntx quality of life (QoL) scale and neurotoxicity and function subscales were inversely associated with CPT 2,000 [−1.8 (−3.5, −0.05), −2.2 (−4.2, −0.2), and −5.4 (−9.8, −0.9), respectively], indicating worsening QoL, impairment, and function as hypoesthesia increases. Conclusions CPT 2,000 may identify impending worsening of patient-reported outcomes such as QoL.
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is increasing with introduction of new and combination cancer pharmacotherapies. This study evaluated associations between clinical and self-report measurements and current perception threshold (CPT), a neuroselective measure of sensory nerve function that may detect asymptomatic CIPN damage. Methods Data for this secondary analysis were from a prospective, observational study using CPT to evaluate CIPN. Bivariate mixed models, accounting for the intraclass correlation between repeated patient assessments, were used to assess the relationship between CPT at each frequency (5, 250, and 2,000 Hz) and each subjective measure (Neuropathic Pain Scale, FACT-GOGntx) and objective measurement (quantitative sensory testing, deep tendon reflexes, and grip strength). Results A total of 29 chemotherapy-naive subjects with various cancer types had a mean age of 56.7 (SD 10.4); nine subjects developed CIPN grade > 1 using NCI CTC-AE criteria. Cold detection thresholds were inversely associated with CPT 5 [b (95% CI) = -2.5(-4.5, -0.5)] and CPT 2,000 [-7.5(-11.8, -3.3)] frequencies. FACT GOG-ntx quality of life (QoL) scale and neurotoxicity and function subscales were inversely associated with CPT 2,000 [-1.8 (-3.5, -0.05), -2.2 (-4.2, -0.2), and -5.4 (-9.8, -0.9), respectively], indicating worsening QoL, impairment, and function as hypoesthesia increases. Conclusions CPT 2,000 may identify impending worsening of patient-reported outcomes such as QoL. Keywords Chemotherapy-induced peripheral neuropathy * CIPN * Chemotherapy * Quality of life * Pain * Cancer
Chemotherapy-induced peripheral neuropathy (CIPN) is increasing with introduction of new and combination cancer pharmacotherapies. This study evaluated associations between clinical and self-report measurements and current perception threshold (CPT), a neuroselective measure of sensory nerve function that may detect asymptomatic CIPN damage. Data for this secondary analysis were from a prospective, observational study using CPT to evaluate CIPN. Bivariate mixed models, accounting for the intraclass correlation between repeated patient assessments, were used to assess the relationship between CPT at each frequency (5, 250, and 2,000 Hz) and each subjective measure (Neuropathic Pain Scale, FACT-GOGntx) and objective measurement (quantitative sensory testing, deep tendon reflexes, and grip strength). A total of 29 chemotherapy-naive subjects with various cancer types had a mean age of 56.7 (SD 10.4); nine subjects developed CIPN grade >1 using NCI CTC-AE criteria. Cold detection thresholds were inversely associated with CPT 5 [b(95 % CI)=-2.5(-4.5, -0.5)] and CPT 2,000 [-7.5(-11.8, -3.3)] frequencies. FACT GOG-ntx quality of life (QoL) scale and neurotoxicity and function subscales were inversely associated with CPT 2,000 [-1.8 (-3.5, -0.05), -2.2 (-4.2, -0.2), and -5.4 (-9.8, -0.9), respectively], indicating worsening QoL, impairment, and function as hypoesthesia increases. CPT 2,000 may identify impending worsening of patient-reported outcomes such as QoL.[PUBLICATION ABSTRACT]
Audience Academic
Author Davenport, Joan M.
Choflet, Amanda
Griffith, Kathleen A.
Zhu, Shijun
Glass, Erica
Dorsey, Susan G.
Pandya, Naimish
Cavaletti, Guido
Couture, Darren J.
Renn, Cynthia L.
Gambill, Nancy
Tanguay, Lori J.
Milliron, Todd
Johantgen, Mary E.
Author_xml – sequence: 1
  givenname: Kathleen A.
  surname: Griffith
  fullname: Griffith, Kathleen A.
  email: Griffith@son.umaryland.edu
  organization: University of Maryland School of Nursing
– sequence: 2
  givenname: Darren J.
  surname: Couture
  fullname: Couture, Darren J.
  organization: Uniformed Services University of the Health Sciences, Naval Medical Center San Diego, CA
– sequence: 3
  givenname: Shijun
  surname: Zhu
  fullname: Zhu, Shijun
  organization: University of Maryland School of Nursing
– sequence: 4
  givenname: Naimish
  surname: Pandya
  fullname: Pandya, Naimish
  organization: MedImmune
– sequence: 5
  givenname: Mary E.
  surname: Johantgen
  fullname: Johantgen, Mary E.
  organization: University of Maryland School of Nursing
– sequence: 6
  givenname: Guido
  surname: Cavaletti
  fullname: Cavaletti, Guido
  organization: Experimental Neurology Unit, Department Surgery and Translational Medicine, University of Milano-Bicocca
– sequence: 7
  givenname: Joan M.
  surname: Davenport
  fullname: Davenport, Joan M.
  organization: University of Maryland School of Nursing
– sequence: 8
  givenname: Lori J.
  surname: Tanguay
  fullname: Tanguay, Lori J.
  organization: Marlene and Stewart Greenebaum Cancer Center, University of Maryland Medical System
– sequence: 9
  givenname: Amanda
  surname: Choflet
  fullname: Choflet, Amanda
  organization: Department of Radiation Oncology & Molecular Sciences, Johns Hopkins Medicine
– sequence: 10
  givenname: Todd
  surname: Milliron
  fullname: Milliron, Todd
  organization: Marlene and Stewart Greenebaum Cancer Center, University of Maryland Medical System
– sequence: 11
  givenname: Erica
  surname: Glass
  fullname: Glass, Erica
  organization: St. Agnes Cancer Institute
– sequence: 12
  givenname: Nancy
  surname: Gambill
  fullname: Gambill, Nancy
  organization: Marlene and Stewart Greenebaum Cancer Center, University of Maryland Medical System
– sequence: 13
  givenname: Cynthia L.
  surname: Renn
  fullname: Renn, Cynthia L.
  email: Renn@son.umaryland.edu
  organization: University of Maryland School of Nursing
– sequence: 14
  givenname: Susan G.
  surname: Dorsey
  fullname: Dorsey, Susan G.
  organization: University of Maryland School of Nursing
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24362842$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1u1DAUhS1URKeFB2CDIrFhk3Id_yUbpKoqtFIlNrC2HMeeuErsYCeV5u1xZtrSVoC8sGR_59j33nOCjnzwBqH3GM4wgPicAFgFJWBSVsDrEl6hDaaElIKQ5ghtoKG4pISxY3SS0i0AFoJVb9BxRQmvalpt0Hx5p4ZFzS74IthC92YMc2-imnal892iTVdMJrppPRsKb5YYJjX3u2JJzm8LvcRo_Lwy2kx7m7mPJvVh6Arlu0IPzjudpebxofQWvbZqSObd_X6Kfn69_HFxVd58_3Z9cX5TasZhLhlpaqVaomvFKqugpZaLrm47S4BZ0WpVC66aSlhbW94yhWtbEcoVbaDWAsgp-nLwnZZ2NJ3OH81FyCm6UcWdDMrJ5zfe9XIb7iRpeCM4zQaf7g1i-LWYNMvRJW2GQXkTliQxw5jkD-zRjy_Q27BEn8tbKRCUMo7_UFs1GOm8DfldvZrKc8Ib4JyzlTr7C5VXZ0ancwasy-fPBB-eFvpY4cOcMyAOgI4hpWis1G7eDyM7u0FikGui5CFRMidKromSaw_xC-WD-f801UGTMuu3Jj7pxT9FvwHmLd8W
CitedBy_id crossref_primary_10_1186_s12885_023_11494_x
crossref_primary_10_1016_j_ygyno_2018_12_002
crossref_primary_10_1007_s11060_015_2049_x
crossref_primary_10_3390_jcm11071862
crossref_primary_10_1007_s00520_023_07734_2
crossref_primary_10_1016_j_pmn_2020_05_005
crossref_primary_10_1097_PHM_0000000000001324
crossref_primary_10_1097_PR9_0000000000000785
crossref_primary_10_1177_1744987115574296
crossref_primary_10_1080_14656566_2017_1415326
crossref_primary_10_1016_j_soncn_2019_150983
crossref_primary_10_3389_fnins_2018_00014
crossref_primary_10_1007_s00520_022_06927_5
crossref_primary_10_1177_15347354231185110
crossref_primary_10_1016_j_pmn_2019_04_004
crossref_primary_10_3802_jgo_2021_32_e73
crossref_primary_10_1016_j_jpainsymman_2016_12_342
crossref_primary_10_1177_17448069231185694
crossref_primary_10_1007_s00520_014_2255_7
crossref_primary_10_1097_AOG_0000000000005419
crossref_primary_10_1007_s40122_017_0092_3
crossref_primary_10_1007_s11764_020_00861_3
crossref_primary_10_1016_j_jpainsymman_2020_10_028
crossref_primary_10_1016_j_jpainsymman_2018_08_017
crossref_primary_10_1007_s00520_017_3806_5
crossref_primary_10_1097_CCO_0000000000000139
crossref_primary_10_12968_ijpn_2017_23_1_13
crossref_primary_10_1016_j_jpainsymman_2017_07_033
crossref_primary_10_1097_WNR_0000000000001910
crossref_primary_10_1016_j_ctarc_2022_100543
crossref_primary_10_3390_cancers16142571
crossref_primary_10_1155_2022_1507291
crossref_primary_10_1093_bja_aex229
crossref_primary_10_1007_s00520_017_3772_y
crossref_primary_10_1002_ar_25161
crossref_primary_10_1007_s00520_019_05006_6
Cites_doi 10.2188/jea.10.1sup_33
10.1016/j.ejca.2005.06.030
10.1007/BF03042662
10.1023/A:1008345613594
10.1016/S0894-1130(12)80314-0
10.2337/diacare.12.9.636
10.1056/NEJMoa032709
10.1186/1744-8069-2-16
10.1006/nbdi.2001.0426
10.1046/j.1525-1497.1999.05208.x
10.1272/jnms.70.129
10.1007/PL00007853
10.1016/S1053-4296(03)00031-6
10.1136/jnnp.52.4.502
10.1682/JRRD.2008.04.0058
10.1136/jnnp.65.5.743
10.1212/WNL.48.2.332
10.1111/j.1464-5491.1991.tb02159.x
10.1097/00000421-198212000-00014
10.1254/jphs.12080SC
10.1111/j.1085-9489.2006.00078.x
10.1136/jnnp.68.5.669
10.1212/WNL.43.12.2723
10.1093/jnci/dji289
10.1016/j.pain.2004.01.021
10.1053/apmr.2002.35656
10.1212/WNL.44.8.1459
10.1016/j.ejca.2008.04.018
10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6
10.1186/1744-8069-4-25
10.1111/j.1525-1438.2007.00794.x
10.1016/S0168-8227(97)01380-6
10.1186/1744-8069-1-13
10.1093/annonc/mds329
10.1200/JCO.2005.04.0543
10.1111/j.1525-1438.2003.13603.x
10.1016/j.pain.2006.01.041
10.1007/BF01150269
10.1016/S0304-3959(01)00363-3
ContentType Journal Article
Copyright Springer-Verlag Berlin Heidelberg 2013
COPYRIGHT 2014 Springer
Springer-Verlag Berlin Heidelberg 2014
Copyright_xml – notice: Springer-Verlag Berlin Heidelberg 2013
– notice: COPYRIGHT 2014 Springer
– notice: Springer-Verlag Berlin Heidelberg 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
0-V
3V.
7RV
7X7
7XB
88E
88J
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
ALSLI
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HEHIP
K9.
KB0
M0S
M1P
M2R
M2S
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
POGQB
PPXIY
PQEST
PQQKQ
PQUKI
PRQQA
Q9U
7X8
5PM
DOI 10.1007/s00520-013-2068-0
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Social Sciences Premium Collection
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Social Science Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
Social Science Premium Collection
ProQuest Central Essentials Local Electronic Collection Information
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Sociology Collection (OCUL)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
Medical Database
Social Science Database
Sociology Database (OCUL)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest Sociology & Social Sciences Collection
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest One Social Sciences
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Social Science Journals (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Sociology & Social Sciences Collection
ProQuest Pharma Collection
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Sociology Collection
ProQuest Central (New)
ProQuest Sociology
ProQuest Medical Library (Alumni)
Social Science Premium Collection
ProQuest One Social Sciences
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Sociology Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Social Science Journals
ProQuest Medical Library
ProQuest Social Sciences Premium Collection
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


ProQuest Central Student
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Nursing
EISSN 1433-7339
EndPage 1169
ExternalDocumentID PMC3969764
3258702891
A369066651
24362842
10_1007_s00520_013_2068_0
Genre Research Support, Non-U.S. Gov't
Journal Article
Observational Study
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NINR NIH HHS
  grantid: P30 NR011396
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
0-V
04C
06C
06D
0R~
0VY
123
1N0
1SB
2.D
203
28-
29Q
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3V.
4.4
406
408
409
40D
40E
53G
5QI
5VS
67Z
6NX
6PF
78A
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABUWZ
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHVE
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADOJX
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFJLC
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALSLI
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARALO
ARMRJ
ASOEW
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BMSDO
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
ECF
ECT
EIHBH
EIOEI
EJD
EMOBN
EN4
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HEHIP
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
IHE
IHR
IJ-
IKXTQ
IMOTQ
INH
INR
ITC
ITM
IWAJR
IXC
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
J5H
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M2R
M2S
M4Y
MA-
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UDS
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
YLTOR
Z45
Z7U
Z82
Z83
Z87
Z8O
Z8V
Z8W
Z91
ZMTXR
ZOVNA
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
POGQB
PPXIY
PRQQA
AEIIB
PMFND
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c560t-5398aab3c8a52fa0b4f67d8bdf305f7bca876a927ff8f6b5a18f2346a4908c703
IEDL.DBID 7X7
ISSN 0941-4355
1433-7339
IngestDate Thu Aug 21 17:44:25 EDT 2025
Fri Sep 05 10:08:25 EDT 2025
Sat Jul 26 02:34:31 EDT 2025
Tue Jun 17 20:48:04 EDT 2025
Tue Jun 10 20:28:55 EDT 2025
Mon Jul 21 05:52:59 EDT 2025
Thu Apr 24 22:51:44 EDT 2025
Tue Jul 01 02:29:59 EDT 2025
Fri Feb 21 02:34:42 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Chemotherapy
Pain
CIPN
Chemotherapy-induced peripheral neuropathy
Quality of life
Cancer
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c560t-5398aab3c8a52fa0b4f67d8bdf305f7bca876a927ff8f6b5a18f2346a4908c703
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
Co-first authors
PMID 24362842
PQID 1510744561
PQPubID 326297
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3969764
proquest_miscellaneous_1511392764
proquest_journals_1510744561
gale_infotracmisc_A369066651
gale_infotracacademiconefile_A369066651
pubmed_primary_24362842
crossref_citationtrail_10_1007_s00520_013_2068_0
crossref_primary_10_1007_s00520_013_2068_0
springer_journals_10_1007_s00520_013_2068_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-05-01
PublicationDateYYYYMMDD 2014-05-01
PublicationDate_xml – month: 05
  year: 2014
  text: 2014-05-01
  day: 01
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationTitle Supportive care in cancer
PublicationTitleAbbrev Support Care Cancer
PublicationTitleAlternate Support Care Cancer
PublicationYear 2014
Publisher Springer Berlin Heidelberg
Springer
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer
– name: Springer Nature B.V
References Felix, Widerstrom (CR37) 2009; 46
Roytta, Raine (CR9) 1985; 14
de Sonnaville (CR36) 1997; 35
Katims (CR22) 1987; 68
Nishimura (CR27) 2004; 31
Cavaletti (CR31) 2013; 24
Galer, Jensen (CR32) 1997; 48
Rendell (CR25) 1989; 52
Oken (CR14) 1982; 5
Doi (CR29) 2003; 70
Chaudhry (CR7) 1994; 44
Postma, Heimans (CR5) 2000; 11
Mielke, Sparreboom, Mross (CR4) 2006; 42
Dougherty (CR10) 2004; 109
Masson, Boulton (CR26) 1991; 8
Quasthoff, Hartung (CR6) 2002; 249
Hilz, Dutsch, Neundorfer (CR38) 1998; 93
Martina (CR39) 1998; 65
Calhoun (CR33) 2003; 13
Huang (CR34) 2007; 17
Merkies (CR40) 2000; 68
Matsumoto (CR19) 2006; 2
Andre (CR12) 2004; 350
Koga (CR21) 2005; 1
Trotti, Colevas, Setser (CR13) 2003; 13
Edwards (CR1) 2005; 97
Matsumoto (CR20) 2008; 4
Bell-Krotoski (CR35) 1995; 8
CR2
Hallett (CR42) 1993; 43
Wolf (CR17) 2008; 44
Takekuma (CR23) 2000; 10
Smieja (CR41) 1999; 14
Ma (CR18) 2012; 119
Lee, Swain (CR3) 2006; 24
Tack (CR28) 1994; 44
Fischer (CR11) 2001; 8
CR44
Rendell (CR24) 1989; 12
Richardson (CR43) 2002; 83
Rolke, Baron, Maier (CR30) 2006; 123
Polomano (CR8) 2001; 94
Miller (CR15) 1981; 47
Cavaletti (CR16) 2006; 11
M Matsumoto (2068_CR20) 2008; 4
T Andre (2068_CR12) 2004; 350
A Trotti (2068_CR13) 2003; 13
SJ Fischer (2068_CR11) 2001; 8
TJ Postma (2068_CR5) 2000; 11
S Quasthoff (2068_CR6) 2002; 249
MJ Hilz (2068_CR38) 1998; 93
S Mielke (2068_CR4) 2006; 42
G Cavaletti (2068_CR16) 2006; 11
BS Galer (2068_CR32) 1997; 48
HQ Huang (2068_CR34) 2007; 17
IS Merkies (2068_CR40) 2000; 68
E Felix (2068_CR37) 2009; 46
G Cavaletti (2068_CR31) 2013; 24
RC Polomano (2068_CR8) 2001; 94
MM Oken (2068_CR14) 1982; 5
EA Calhoun (2068_CR33) 2003; 13
M Smieja (2068_CR41) 1999; 14
MS Rendell (2068_CR24) 1989; 12
M Roytta (2068_CR9) 1985; 14
JJ Lee (2068_CR3) 2006; 24
JJ Katims (2068_CR22) 1987; 68
PM Dougherty (2068_CR10) 2004; 109
2068_CR44
S Wolf (2068_CR17) 2008; 44
D Doi (2068_CR29) 2003; 70
JA Bell-Krotoski (2068_CR35) 1995; 8
2068_CR2
M Hallett (2068_CR42) 1993; 43
BK Edwards (2068_CR1) 2005; 97
R Rolke (2068_CR30) 2006; 123
EA Masson (2068_CR26) 1991; 8
CJ Tack (2068_CR28) 1994; 44
JJ Sonnaville de (2068_CR36) 1997; 35
L Ma (2068_CR18) 2012; 119
V Chaudhry (2068_CR7) 1994; 44
K Koga (2068_CR21) 2005; 1
MS Rendell (2068_CR25) 1989; 52
M Matsumoto (2068_CR19) 2006; 2
AB Miller (2068_CR15) 1981; 47
IS Martina (2068_CR39) 1998; 65
K Takekuma (2068_CR23) 2000; 10
JK Richardson (2068_CR43) 2002; 83
H Nishimura (2068_CR27) 2004; 31
9179471 - Diabetes Res Clin Pract. 1997 Mar;35(2-3):149-56
11741398 - Neurobiol Dis. 2001 Dec;8(6):1027-35
16787511 - J Peripher Nerv Syst. 2006 Jun;11(2):135-41
11954874 - J Neurol. 2002 Jan;249(1):9-17
16681855 - Mol Pain. 2006;2:16
12422324 - Arch Phys Med Rehabil. 2002 Nov;83(11):1553-8
3032128 - Arch Phys Med Rehabil. 1987 Apr;68(4):210-3
16575015 - J Clin Oncol. 2006 Apr 1;24(10):1633-42
16293411 - Eur J Cancer. 2006 Jan;42(1):24-30
7459811 - Cancer. 1981 Jan 1;47(1):207-14
17362317 - Int J Gynecol Cancer. 2007 Mar-Apr;17(2):387-93
15082135 - Pain. 2004 May;109(1-2):132-42
2861255 - J Neurocytol. 1985 Feb;14(1):157-75
18620588 - Mol Pain. 2008;4:25
2791826 - Diabetes Care. 1989 Oct;12(9):636-40
8208323 - Neth J Med. 1994 Feb;44(2):41-9
10835826 - J Epidemiol. 2000 Apr;10(1 Suppl):S33-8
16697110 - Pain. 2006 Aug;123(3):231-43
1825961 - Diabet Med. 1991;8 Spec No:S63-6
9040716 - Neurology. 1997 Feb;48(2):332-8
10907941 - Ann Oncol. 2000 May;11(5):509-13
9792019 - Med Klin (Munich). 1998 Sep 15;93(9):533-40
15175436 - N Engl J Med. 2004 Jun 3;350(23):2343-51
7802740 - Neurology. 1993 Dec;43(12):2723
8058149 - Neurology. 1994 Aug;44(8):1459-62
22785019 - J Pharmacol Sci. 2012;119(3):282-6
9810949 - J Neurol Neurosurg Psychiatry. 1998 Nov;65(5):743-7
14675309 - Int J Gynecol Cancer. 2003 Nov-Dec;13(6):741-8
7550627 - J Hand Ther. 1995 Apr-Jun;8(2):155-62
15114714 - Gan To Kagaku Ryoho. 2004 Apr;31(4):627-30
19533521 - J Rehabil Res Dev. 2009;46(1):69-83
18571399 - Eur J Cancer. 2008 Jul;44(11):1507-15
10417599 - J Gen Intern Med. 1999 Jul;14(7):418-24
16204691 - J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27
2738593 - J Neurol Neurosurg Psychiatry. 1989 Apr;52(4):502-11
12903007 - Semin Radiat Oncol. 2003 Jul;13(3):176-81
7165009 - Am J Clin Oncol. 1982 Dec;5(6):649-55
22910842 - Ann Oncol. 2013 Feb;24(2):454-62
12802373 - J Nippon Med Sch. 2003 Apr;70(2):129-34
10766905 - J Neurol Neurosurg Psychiatry. 2000 May;68(5):669-71
15813963 - Mol Pain. 2005;1:13
11731066 - Pain. 2001 Dec;94(3):293-304
References_xml – volume: 10
  start-page: S33
  issue: 1
  year: 2000
  end-page: S38
  ident: CR23
  article-title: Age and gender differences in skin sensory threshold assessed by current perception in community dwelling Japanese
  publication-title: J Epidemiol
  doi: 10.2188/jea.10.1sup_33
– volume: 42
  start-page: 24
  issue: 1
  year: 2006
  end-page: 30
  ident: CR4
  article-title: Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2005.06.030
– volume: 93
  start-page: 533
  issue: 9
  year: 1998
  end-page: 540
  ident: CR38
  article-title: Autonomic disorders in polyneuropathies
  publication-title: Med Klin (Munich)
  doi: 10.1007/BF03042662
– volume: 11
  start-page: 509
  issue: 5
  year: 2000
  end-page: 513
  ident: CR5
  article-title: Grading of chemotherapy-induced peripheral neuropathy
  publication-title: Ann Oncol
  doi: 10.1023/A:1008345613594
– volume: 8
  start-page: 155
  issue: 2
  year: 1995
  end-page: 162
  ident: CR35
  article-title: Threshold detection and Semmes-Weinstein monofilaments
  publication-title: J Hand Ther
  doi: 10.1016/S0894-1130(12)80314-0
– volume: 44
  start-page: 41
  issue: 2
  year: 1994
  end-page: 49
  ident: CR28
  article-title: Comparison of clinical examination, current and vibratory perception threshold in diabetic polyneuropathy
  publication-title: Neth J Med
– ident: CR2
– volume: 12
  start-page: 636
  issue: 9
  year: 1989
  end-page: 640
  ident: CR24
  article-title: Mapping diabetic sensory neuropathy by current perception threshold testing
  publication-title: Diabetes Care
  doi: 10.2337/diacare.12.9.636
– volume: 350
  start-page: 2343
  issue: 23
  year: 2004
  end-page: 2351
  ident: CR12
  article-title: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa032709
– volume: 2
  start-page: 16
  year: 2006
  ident: CR19
  article-title: Characterization of three different sensory fibers by use of neonatal capsaicin treatment, spinal antagonism and a novel electrical stimulation-induced paw flexion test
  publication-title: Mol Pain
  doi: 10.1186/1744-8069-2-16
– volume: 8
  start-page: 1027
  issue: 6
  year: 2001
  end-page: 1035
  ident: CR11
  article-title: Alterations in cell cycle regulation underlie cisplatin induced apoptosis of dorsal root ganglion neurons in vivo
  publication-title: Neurobiol Dis
  doi: 10.1006/nbdi.2001.0426
– volume: 14
  start-page: 418
  issue: 7
  year: 1999
  end-page: 424
  ident: CR41
  article-title: Clinical examination for the detection of protective sensation in the feet of diabetic patients. International Cooperative Group for Clinical Examination Research
  publication-title: J Gen Intern Med
  doi: 10.1046/j.1525-1497.1999.05208.x
– volume: 70
  start-page: 129
  issue: 2
  year: 2003
  end-page: 134
  ident: CR29
  article-title: Evaluation of the neurotoxicity of paclitaxel and carboplatin by current perception threshold in ovarian cancer patients
  publication-title: J Nihon Med Sch
  doi: 10.1272/jnms.70.129
– volume: 249
  start-page: 9
  issue: 1
  year: 2002
  end-page: 17
  ident: CR6
  article-title: Chemotherapy-induced peripheral neuropathy
  publication-title: J Neurol
  doi: 10.1007/PL00007853
– volume: 13
  start-page: 176
  issue: 3
  year: 2003
  end-page: 181
  ident: CR13
  article-title: CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
  publication-title: Semin Radiat Oncol
  doi: 10.1016/S1053-4296(03)00031-6
– volume: 52
  start-page: 502
  issue: 4
  year: 1989
  end-page: 511
  ident: CR25
  article-title: A comparison of nerve conduction velocities and current perception thresholds as correlates of clinical severity of diabetic sensory neuropathy
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.52.4.502
– volume: 46
  start-page: 69
  year: 2009
  end-page: 84
  ident: CR37
  article-title: Reliability and validity of quantitative sensory testing in persons with spinal cord injury and neuropathic pain
  publication-title: J Rehabil Res Dev
  doi: 10.1682/JRRD.2008.04.0058
– volume: 65
  start-page: 743
  issue: 5
  year: 1998
  end-page: 747
  ident: CR39
  article-title: Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.65.5.743
– volume: 48
  start-page: 332
  issue: 2
  year: 1997
  end-page: 338
  ident: CR32
  article-title: Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale
  publication-title: Neurology
  doi: 10.1212/WNL.48.2.332
– volume: 8
  start-page: S63
  issue: Spec No
  year: 1991
  end-page: S66
  ident: CR26
  article-title: The Neurometer: validation and comparison with conventional tests for diabetic neuropathy
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.1991.tb02159.x
– volume: 5
  start-page: 649
  issue: 6
  year: 1982
  end-page: 655
  ident: CR14
  article-title: Toxicity and response criteria of the Eastern Cooperative Oncology Group
  publication-title: Am J Clin Oncol
  doi: 10.1097/00000421-198212000-00014
– volume: 119
  start-page: 282
  issue: 3
  year: 2012
  end-page: 286
  ident: CR18
  article-title: Single application of A2 NTX, a botulinum toxin A2 subunit, prevents chronic pain over long periods in both diabetic and spinal cord injury-induced neuropathic pain models
  publication-title: J Pharmacol Sci
  doi: 10.1254/jphs.12080SC
– volume: 11
  start-page: 135
  issue: 2
  year: 2006
  end-page: 141
  ident: CR16
  article-title: Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity
  publication-title: J Peripher Nerv Syst
  doi: 10.1111/j.1085-9489.2006.00078.x
– volume: 68
  start-page: 669
  issue: 5
  year: 2000
  end-page: 671
  ident: CR40
  article-title: Reliability and responsiveness of a graduated tuning fork in immune mediated polyneuropathies. The Inflammatory Neuropathy Cause and Treatment (INCAT) Group
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.68.5.669
– volume: 43
  start-page: 2723
  issue: 12
  year: 1993
  ident: CR42
  article-title: NINDS myotatic reflex scale
  publication-title: Neurology
  doi: 10.1212/WNL.43.12.2723
– volume: 97
  start-page: 1407
  issue: 19
  year: 2005
  end-page: 1427
  ident: CR1
  article-title: Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/dji289
– volume: 109
  start-page: 132
  issue: 1–2
  year: 2004
  end-page: 142
  ident: CR10
  article-title: Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients
  publication-title: Pain
  doi: 10.1016/j.pain.2004.01.021
– volume: 83
  start-page: 1553
  issue: 11
  year: 2002
  end-page: 1558
  ident: CR43
  article-title: The clinical identification of peripheral neuropathy among older persons
  publication-title: Arch Phys Med Rehabil
  doi: 10.1053/apmr.2002.35656
– volume: 44
  start-page: 1459
  issue: 8
  year: 1994
  end-page: 1462
  ident: CR7
  article-title: Inter- and intraexaminer reliability of nerve conduction measurements in patients with diabetic neuropathy
  publication-title: Neurology
  doi: 10.1212/WNL.44.8.1459
– ident: CR44
– volume: 44
  start-page: 1507
  issue: 11
  year: 2008
  end-page: 1515
  ident: CR17
  article-title: Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2008.04.018
– volume: 47
  start-page: 207
  issue: 1
  year: 1981
  end-page: 214
  ident: CR15
  article-title: Reporting results of cancer treatment
  publication-title: Cancer
  doi: 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6
– volume: 4
  start-page: 25
  year: 2008
  ident: CR20
  article-title: Pharmacological switch in Abeta-fiber stimulation-induced spinal transmission in mice with partial sciatic nerve injury
  publication-title: Mol Pain
  doi: 10.1186/1744-8069-4-25
– volume: 17
  start-page: 387
  issue: 2
  year: 2007
  end-page: 393
  ident: CR34
  article-title: Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study
  publication-title: Int J Gynecol Cancer
  doi: 10.1111/j.1525-1438.2007.00794.x
– volume: 35
  start-page: 149
  issue: 2–3
  year: 1997
  end-page: 156
  ident: CR36
  article-title: The prevalence and determinants of foot ulceration in type II diabetic patients in a primary health care setting
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/S0168-8227(97)01380-6
– volume: 1
  start-page: 13
  year: 2005
  ident: CR21
  article-title: Selective activation of primary afferent fibers evaluated by sine-wave electrical stimulation
  publication-title: Mol Pain
  doi: 10.1186/1744-8069-1-13
– volume: 31
  start-page: 627
  issue: 4
  year: 2004
  end-page: 630
  ident: CR27
  article-title: Weekly paclitaxel therapy for locoregional lymph node recurrence of estrogen-receptor-negative breast cancer
  publication-title: Gan To Kagaku Ryoho
– volume: 24
  start-page: 454
  issue: 2
  year: 2013
  end-page: 462
  ident: CR31
  article-title: The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mds329
– volume: 24
  start-page: 1633
  issue: 10
  year: 2006
  end-page: 1642
  ident: CR3
  article-title: Peripheral neuropathy induced by microtubule-stabilizing agents
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.04.0543
– volume: 13
  start-page: 741
  issue: 6
  year: 2003
  end-page: 748
  ident: CR33
  article-title: Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy
  publication-title: Int J Gynecol Cancer
  doi: 10.1111/j.1525-1438.2003.13603.x
– volume: 123
  start-page: 231
  issue: 3
  year: 2006
  end-page: 243
  ident: CR30
  article-title: Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values
  publication-title: Pain
  doi: 10.1016/j.pain.2006.01.041
– volume: 14
  start-page: 157
  issue: 1
  year: 1985
  end-page: 175
  ident: CR9
  article-title: Taxol-induced neuropathy: further ultrastructural studies of nerve fibre changes in situ
  publication-title: J Neurocytol
  doi: 10.1007/BF01150269
– volume: 68
  start-page: 210
  issue: 4
  year: 1987
  end-page: 213
  ident: CR22
  article-title: Constant current sine wave transcutaneous nerve stimulation for the evaluation of peripheral neuropathy
  publication-title: Arch Phys Med Rehabil
– volume: 94
  start-page: 293
  issue: 3
  year: 2001
  end-page: 304
  ident: CR8
  article-title: A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel
  publication-title: Pain
  doi: 10.1016/S0304-3959(01)00363-3
– volume: 13
  start-page: 176
  issue: 3
  year: 2003
  ident: 2068_CR13
  publication-title: Semin Radiat Oncol
  doi: 10.1016/S1053-4296(03)00031-6
– volume: 8
  start-page: 1027
  issue: 6
  year: 2001
  ident: 2068_CR11
  publication-title: Neurobiol Dis
  doi: 10.1006/nbdi.2001.0426
– ident: 2068_CR2
– volume: 1
  start-page: 13
  year: 2005
  ident: 2068_CR21
  publication-title: Mol Pain
  doi: 10.1186/1744-8069-1-13
– volume: 5
  start-page: 649
  issue: 6
  year: 1982
  ident: 2068_CR14
  publication-title: Am J Clin Oncol
  doi: 10.1097/00000421-198212000-00014
– volume: 43
  start-page: 2723
  issue: 12
  year: 1993
  ident: 2068_CR42
  publication-title: Neurology
  doi: 10.1212/WNL.43.12.2723
– volume: 70
  start-page: 129
  issue: 2
  year: 2003
  ident: 2068_CR29
  publication-title: J Nihon Med Sch
  doi: 10.1272/jnms.70.129
– volume: 12
  start-page: 636
  issue: 9
  year: 1989
  ident: 2068_CR24
  publication-title: Diabetes Care
  doi: 10.2337/diacare.12.9.636
– volume: 46
  start-page: 69
  year: 2009
  ident: 2068_CR37
  publication-title: J Rehabil Res Dev
  doi: 10.1682/JRRD.2008.04.0058
– volume: 83
  start-page: 1553
  issue: 11
  year: 2002
  ident: 2068_CR43
  publication-title: Arch Phys Med Rehabil
  doi: 10.1053/apmr.2002.35656
– volume: 97
  start-page: 1407
  issue: 19
  year: 2005
  ident: 2068_CR1
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/dji289
– volume: 44
  start-page: 1507
  issue: 11
  year: 2008
  ident: 2068_CR17
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2008.04.018
– volume: 35
  start-page: 149
  issue: 2–3
  year: 1997
  ident: 2068_CR36
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/S0168-8227(97)01380-6
– volume: 11
  start-page: 135
  issue: 2
  year: 2006
  ident: 2068_CR16
  publication-title: J Peripher Nerv Syst
  doi: 10.1111/j.1085-9489.2006.00078.x
– volume: 10
  start-page: S33
  issue: 1
  year: 2000
  ident: 2068_CR23
  publication-title: J Epidemiol
  doi: 10.2188/jea.10.1sup_33
– volume: 123
  start-page: 231
  issue: 3
  year: 2006
  ident: 2068_CR30
  publication-title: Pain
  doi: 10.1016/j.pain.2006.01.041
– volume: 4
  start-page: 25
  year: 2008
  ident: 2068_CR20
  publication-title: Mol Pain
  doi: 10.1186/1744-8069-4-25
– volume: 52
  start-page: 502
  issue: 4
  year: 1989
  ident: 2068_CR25
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.52.4.502
– volume: 65
  start-page: 743
  issue: 5
  year: 1998
  ident: 2068_CR39
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.65.5.743
– volume: 350
  start-page: 2343
  issue: 23
  year: 2004
  ident: 2068_CR12
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa032709
– volume: 44
  start-page: 41
  issue: 2
  year: 1994
  ident: 2068_CR28
  publication-title: Neth J Med
– volume: 31
  start-page: 627
  issue: 4
  year: 2004
  ident: 2068_CR27
  publication-title: Gan To Kagaku Ryoho
– volume: 44
  start-page: 1459
  issue: 8
  year: 1994
  ident: 2068_CR7
  publication-title: Neurology
  doi: 10.1212/WNL.44.8.1459
– volume: 48
  start-page: 332
  issue: 2
  year: 1997
  ident: 2068_CR32
  publication-title: Neurology
  doi: 10.1212/WNL.48.2.332
– volume: 47
  start-page: 207
  issue: 1
  year: 1981
  ident: 2068_CR15
  publication-title: Cancer
  doi: 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6
– volume: 109
  start-page: 132
  issue: 1–2
  year: 2004
  ident: 2068_CR10
  publication-title: Pain
  doi: 10.1016/j.pain.2004.01.021
– volume: 13
  start-page: 741
  issue: 6
  year: 2003
  ident: 2068_CR33
  publication-title: Int J Gynecol Cancer
  doi: 10.1111/j.1525-1438.2003.13603.x
– volume: 14
  start-page: 418
  issue: 7
  year: 1999
  ident: 2068_CR41
  publication-title: J Gen Intern Med
  doi: 10.1046/j.1525-1497.1999.05208.x
– ident: 2068_CR44
– volume: 93
  start-page: 533
  issue: 9
  year: 1998
  ident: 2068_CR38
  publication-title: Med Klin (Munich)
  doi: 10.1007/BF03042662
– volume: 24
  start-page: 1633
  issue: 10
  year: 2006
  ident: 2068_CR3
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.04.0543
– volume: 94
  start-page: 293
  issue: 3
  year: 2001
  ident: 2068_CR8
  publication-title: Pain
  doi: 10.1016/S0304-3959(01)00363-3
– volume: 119
  start-page: 282
  issue: 3
  year: 2012
  ident: 2068_CR18
  publication-title: J Pharmacol Sci
  doi: 10.1254/jphs.12080SC
– volume: 8
  start-page: S63
  issue: Spec No
  year: 1991
  ident: 2068_CR26
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.1991.tb02159.x
– volume: 42
  start-page: 24
  issue: 1
  year: 2006
  ident: 2068_CR4
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2005.06.030
– volume: 11
  start-page: 509
  issue: 5
  year: 2000
  ident: 2068_CR5
  publication-title: Ann Oncol
  doi: 10.1023/A:1008345613594
– volume: 17
  start-page: 387
  issue: 2
  year: 2007
  ident: 2068_CR34
  publication-title: Int J Gynecol Cancer
  doi: 10.1111/j.1525-1438.2007.00794.x
– volume: 249
  start-page: 9
  issue: 1
  year: 2002
  ident: 2068_CR6
  publication-title: J Neurol
  doi: 10.1007/PL00007853
– volume: 8
  start-page: 155
  issue: 2
  year: 1995
  ident: 2068_CR35
  publication-title: J Hand Ther
  doi: 10.1016/S0894-1130(12)80314-0
– volume: 2
  start-page: 16
  year: 2006
  ident: 2068_CR19
  publication-title: Mol Pain
  doi: 10.1186/1744-8069-2-16
– volume: 24
  start-page: 454
  issue: 2
  year: 2013
  ident: 2068_CR31
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mds329
– volume: 68
  start-page: 669
  issue: 5
  year: 2000
  ident: 2068_CR40
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.68.5.669
– volume: 14
  start-page: 157
  issue: 1
  year: 1985
  ident: 2068_CR9
  publication-title: J Neurocytol
  doi: 10.1007/BF01150269
– volume: 68
  start-page: 210
  issue: 4
  year: 1987
  ident: 2068_CR22
  publication-title: Arch Phys Med Rehabil
– reference: 16204691 - J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27
– reference: 8058149 - Neurology. 1994 Aug;44(8):1459-62
– reference: 10907941 - Ann Oncol. 2000 May;11(5):509-13
– reference: 12903007 - Semin Radiat Oncol. 2003 Jul;13(3):176-81
– reference: 15813963 - Mol Pain. 2005;1:13
– reference: 18571399 - Eur J Cancer. 2008 Jul;44(11):1507-15
– reference: 9040716 - Neurology. 1997 Feb;48(2):332-8
– reference: 9179471 - Diabetes Res Clin Pract. 1997 Mar;35(2-3):149-56
– reference: 22785019 - J Pharmacol Sci. 2012;119(3):282-6
– reference: 22910842 - Ann Oncol. 2013 Feb;24(2):454-62
– reference: 2791826 - Diabetes Care. 1989 Oct;12(9):636-40
– reference: 7802740 - Neurology. 1993 Dec;43(12):2723
– reference: 3032128 - Arch Phys Med Rehabil. 1987 Apr;68(4):210-3
– reference: 7550627 - J Hand Ther. 1995 Apr-Jun;8(2):155-62
– reference: 10835826 - J Epidemiol. 2000 Apr;10(1 Suppl):S33-8
– reference: 10417599 - J Gen Intern Med. 1999 Jul;14(7):418-24
– reference: 16787511 - J Peripher Nerv Syst. 2006 Jun;11(2):135-41
– reference: 15114714 - Gan To Kagaku Ryoho. 2004 Apr;31(4):627-30
– reference: 14675309 - Int J Gynecol Cancer. 2003 Nov-Dec;13(6):741-8
– reference: 16575015 - J Clin Oncol. 2006 Apr 1;24(10):1633-42
– reference: 19533521 - J Rehabil Res Dev. 2009;46(1):69-83
– reference: 12422324 - Arch Phys Med Rehabil. 2002 Nov;83(11):1553-8
– reference: 16293411 - Eur J Cancer. 2006 Jan;42(1):24-30
– reference: 11741398 - Neurobiol Dis. 2001 Dec;8(6):1027-35
– reference: 2738593 - J Neurol Neurosurg Psychiatry. 1989 Apr;52(4):502-11
– reference: 15175436 - N Engl J Med. 2004 Jun 3;350(23):2343-51
– reference: 11731066 - Pain. 2001 Dec;94(3):293-304
– reference: 7165009 - Am J Clin Oncol. 1982 Dec;5(6):649-55
– reference: 8208323 - Neth J Med. 1994 Feb;44(2):41-9
– reference: 12802373 - J Nippon Med Sch. 2003 Apr;70(2):129-34
– reference: 1825961 - Diabet Med. 1991;8 Spec No:S63-6
– reference: 11954874 - J Neurol. 2002 Jan;249(1):9-17
– reference: 9792019 - Med Klin (Munich). 1998 Sep 15;93(9):533-40
– reference: 10766905 - J Neurol Neurosurg Psychiatry. 2000 May;68(5):669-71
– reference: 15082135 - Pain. 2004 May;109(1-2):132-42
– reference: 9810949 - J Neurol Neurosurg Psychiatry. 1998 Nov;65(5):743-7
– reference: 16681855 - Mol Pain. 2006;2:16
– reference: 18620588 - Mol Pain. 2008;4:25
– reference: 2861255 - J Neurocytol. 1985 Feb;14(1):157-75
– reference: 16697110 - Pain. 2006 Aug;123(3):231-43
– reference: 17362317 - Int J Gynecol Cancer. 2007 Mar-Apr;17(2):387-93
– reference: 7459811 - Cancer. 1981 Jan 1;47(1):207-14
SSID ssj0017752
Score 2.2765942
Snippet Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is increasing with introduction of new and combination cancer pharmacotherapies. This study evaluated...
Chemotherapy-induced peripheral neuropathy (CIPN) is increasing with introduction of new and combination cancer pharmacotherapies. This study evaluated...
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is increasing with introduction of new and combination cancer pharmacotherapies. This study evaluated...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1161
SubjectTerms Antineoplastic Agents - adverse effects
Antineoplastic Agents - therapeutic use
Cancer
Chemotherapy
Female
Humans
Male
Medicine
Medicine & Public Health
Middle Aged
Neoplasms - drug therapy
Neurological disorders
Neurotoxicity Syndromes - diagnosis
Nursing
Nursing Research
Oncology
Original Article
Pain
Pain Medicine
Peripheral Nervous System Diseases - chemically induced
Peripheral Nervous System Diseases - diagnosis
Prospective Studies
Quality of Life
Rehabilitation Medicine
Self Report
Sensory Thresholds - physiology
SummonAdditionalLinks – databaseName: SpringerLINK - Czech Republic Consortium
  dbid: AGYKE
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6hrUBceJRHAwUZCQkJ5Cpx_NrjCm2pQOXUSuUU2U5MESVbsdlD-fWMHSc0K0Dq2RPLccbjbzIz3wC8llqYpjSOepdzyrlqqPa-pkIIpbyV3pehUPj4szw65R_PxFmq414P2e5DSDJa6rHYLaZs0NCNgOVSU_TTd0TwT2aws_jw5dNyDB4oFRvtoOOC7hHep0Mw82-TTK6jbaN87VbazpjcCpvG2-jwPpwM79EnoXw_2HT2wP3aoni84Ys-gHsJnZJFr04P4VbT7sKd4xR_34Xb6efCI-iWI004WXmCn_5HquW6oujmo8LUJJAoR9aCCxJpM0P34ysSMu2_EtfzQgWZlFhDOlSrdYiGEdPWZCjZJH_4yNeP4fRwefL-iKYODtQhkuqoKOfaGFs6bQTzJrfcS1VrW3s0M15ZZ9AYmzlT3msvrTCF9qzk0oRwpENj9ARm7apt9oCUnLvCG144XfBaeNvwktXWMGa1q1WTQT58yMolevPQZeOiGomZ475WuK9V2Ncqz-Dt-Mhlz-3xP-E3QTuqcO5xXmdS-QKuLjBoVYsyUD5LKYoM9ieSeF7ddHjQryrZi3WFuAuxXACzGbwah8OTIQeubVabKINwnSnJM3jaq-O4bMYRiGjOMlATRR0FAov4dKT9dh7ZxMu5nMc53w3aeG1Z_9qNZzeSfg53EWfyPk90H2bdz03zArFcZ1-ms_sbxJhB8Q
  priority: 102
  providerName: Springer Nature
Title Evaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations
URI https://link.springer.com/article/10.1007/s00520-013-2068-0
https://www.ncbi.nlm.nih.gov/pubmed/24362842
https://www.proquest.com/docview/1510744561
https://www.proquest.com/docview/1511392764
https://pubmed.ncbi.nlm.nih.gov/PMC3969764
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1433-7339
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017752
  issn: 0941-4355
  databaseCode: AFBBN
  dateStart: 19970101
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1433-7339
  dateEnd: 20171231
  omitProxy: true
  ssIdentifier: ssj0017752
  issn: 0941-4355
  databaseCode: 7X7
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1433-7339
  dateEnd: 20171231
  omitProxy: true
  ssIdentifier: ssj0017752
  issn: 0941-4355
  databaseCode: BENPR
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1433-7339
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017752
  issn: 0941-4355
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1433-7339
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017752
  issn: 0941-4355
  databaseCode: U2A
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96B-KL-G31PCIIghJs871Pssqeh3KHiAvrU0nTRoWze3fbe7j_3pk07V0XvKdCMylpZjIzyUx-Q8hrbZVrhPMs-FwyKU3DbAg1U0oZEyodgsCLwkfH-nApv6zUKh24bVJa5aATo6Ku1x7PyN-DZQJrh-b-w-kZw6pRGF1NJTRuk90CXBWUarMaN1yFMbHiDuxgYJ8EhnWIauYRRFRxTMkSICfasnxil7a18zXztJ06uRU_jWbp4D65l_xJOu8F4AG51bQPyZ2jFDF_RLrFCOdN14ECi_6mO1eXDLbjwNiaIthxRBc4oRHeEqsUX1LMiP9FfY_fhDQpAYZ2wP4NRq2oa2s6XK2kV7jhm8dkebD48emQpUoLzIPH0zElZta5SnjrFA8ur2TQprZVHUAdBFN5B0rTzbgJwQZdKVfYwIXUDsOGHpTGE7LTrtvmGaFCSl8EJwtvC1mrUDVS8LpynFfW16bJSD7Mc-kTDDlWwzgpRwDlyJoSWFMia8o8I2_HLqc9BsdNxG-QeSWuT_iud-maAYwOka7KuUBoZq1VkZG9CSWsKz9tHthfpnW9Ka-kMCOvxmbsiblqbbO-iDTgVnOjZUae9tIyDptLcBis5BkxEzkaCRDte9rS_vkdUb_FTM_iN98NEndtWP-bjec3_8QLchccQNkncO6Rne78onkJTlZX7ceVtE92559_fl3A8-Pi-Nt3eLvk838kding
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxJtAASOBkEARid97QKiCVlva7amV9hYcJwakki3sVmj_FL-RGefR7kr01rMnlpP5PGNnZr4BeKWtcrVwPg0-k6mUpk5tCFWqlDImlDoEQYXCk0M9PpZfpmq6AX_7WhhKq-xtYjTU1czTP_L36JnQ25G7_3j6K6WuURRd7VtotLDYr5d_8Mo2_7D3GfX7mvPdnaNP47TrKpB69O6LVImRda4U3jrFg8tKGbSpbFkFhH4wpXdoINyImxBs0KVyuQ1cSO0oROZxg-C81-C6FJkkrn4zHS54uTGxww_emPBeho68j6JmkbRUcUoBE4hLbdNsxQ-ue4ML7nA9VXMtXhvd4O4duN2dX9l2C7i7sFE39-DGpIvQ34fFzkAfzmaBISR-djVeyxSv_wikihG5cmQzOGGRTpO6Ii8ZZeB_Y77liyKZLuGGLRBuc4qSMddUrC_lZOc85fMHcHwlOngIm82sqR8DE1L6PDiZe5vLSoWyloJXpeO8tL4ydQJZ_50L39GeU_eNk2IgbI6qKVA1BammyBJ4Ozxy2nJ-XCb8hpRXkD3Aeb3ryhpwdcSsVWwLooLWWuUJbK1I4j72q8O9-ovOjsyLc9Qn8HIYpicpN66pZ2dRBo_x3GiZwKMWLcOyucQDipU8AbOCo0GA2MVXR5of3yPLuBjpUZzzXY-4C8v639d4cvlLvICb46PJQXGwd7j_FG7h4VO2yaNbsLn4fVY_wwPeonwedxWDr1e9jf8B4y9jRw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEB9qheKL-G206gqKoIQm-30PIsX2aK0tPli4t7jZZLVQc9W7Ivev-dc5s_lo78C-9XknyybzuZmZ3wC80la5WjifBp_JVEpTpzaEKlVKGRNKHYKgRuHDI713LD9N1GQN_va9MFRW2dvEaKirqad_5FvomdDbkbvfCl1ZxJed8YezXylNkKJMaz9OoxWRg3rxB69vs_f7O8jr15yPd79-3Eu7CQOpR08_T5UYWedK4a1TPLislEGbypZVQDUIpvQOjYUbcROCDbpULreBC6kdpcs8KgvuewNuGiEFlZOZyXDZy42J037w9oR3NHTqfUY1iwCmilM5mEAZ1TbNlnziqme45BpXyzZXcrfRJY7vwO0ulmXbrfDdhbW6uQcbh122_j7MdwcocTYNDMXjZ9fvtUhPmgqFqmIEtByRDU5ZhNakCckLRtX435lvsaOIpiu-YXMUvRllzJhrKta3dbILzPLZAzi-Fh48hPVm2tSPgQkpfR6czL3NZaVCWUvBq9JxXlpfmTqBrP_Ohe8g0GkSx2kxgDdH1hTImoJYU2QJvB0eOWvxP64ifkPMK8g24L7edS0OeDpC2Sq2BcFCa63yBDaXKFGn_fJyz_6isymz4kIDEng5LNOTVCfX1NPzSIMhPTdaJvColZbh2FxisGIlT8AsydFAQEjjyyvNyY-IOC5GehT3fNdL3KVj_e9rPLn6JV7ABipw8Xn_6OAp3MI4VLZ1pJuwPv99Xj_DWG9ePo9KxeDbdWvxP41qZ4I
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+chemotherapy-induced+peripheral+neuropathy+using+current+perception+threshold+and+clinical+evaluations&rft.jtitle=Supportive+care+in+cancer&rft.au=Griffith%2C+Kathleen+A.&rft.au=Couture%2C+Darren+J.&rft.au=Zhu%2C+Shijun&rft.au=Pandya%2C+Naimish&rft.date=2014-05-01&rft.issn=0941-4355&rft.eissn=1433-7339&rft.volume=22&rft.issue=5&rft.spage=1161&rft.epage=1169&rft_id=info:doi/10.1007%2Fs00520-013-2068-0&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00520_013_2068_0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0941-4355&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0941-4355&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0941-4355&client=summon